Skip to content

Patient-derived Stem Cell Models of Anorexia Nervosa

Generation and Analysis of Patient-derived Stem Cell Models of Hypothalamic Neurons and Microglia in Anorexia Nervosa

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06259500
Acronym
ANSTEM
Enrollment
20
Registered
2024-02-14
Start date
2022-08-25
Completion date
2026-12-31
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa

Brief summary

Experimental and genetic data, as well as brain imaging, support a role of the hypothalamic Arcuate nucleus neurons and their communication with surrounding microglia in anorectic conditions, but it has until recently not been possible to explore these cells at a molecular level in anorexia nervosa (AN) patients. This attributed to the obvious lack of valid tissue and non-invasive imaging techniques of high enough resolution. Stem cell models have evolved as a useful tool for the exploration of other neuropsychiatric disorders with a comparably high genetic contribution as AN. The investigators will here use patient-derived induced pluripotent stem cells (iPSCs) to profile Arc neurons and peripheral blood mononuclear cell (PBMC) derived microglia in AN, thus defining molecules to explore as drug targets.

Interventions

OTHERobservational

Profiling the function of iPSC derived Arcuate neurons and PBMC derived microglia

Sponsors

Karolinska Institutet
Lead SponsorOTHER
The Swedish Research Council
CollaboratorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years

Inclusion criteria

anorexia nervosa: * female * 18-45 years of age * AN restrictive diagnosis as main diagnosis * more than 5 years duration

Exclusion criteria

anorexia nervosa: \- Inclusion Criteria healthy control: * female * 18-45 years of age * BMI 18,5 - 25

Design outcomes

Primary

MeasureTime frameDescription
Microglia function and transcriptomic profiling2025phagocytic and immune activation capacity and whole transcriptomic profiling, anorexia nervosa vs healthy controls
Arcuate neuron function and transcriptomic profiling2026Electrical activity, transmitter release and whole transcriptomic profiling of iPSC derived Arcuate neurons, anorexia nervosa vs healthy controls

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026